Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells

por Cavet, Megan E., Harrington, Karen L., Ward, Keith W., Zhang, Jin-Zhong
Publicado 2010

Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells

por Cavet, Megan E., Harrington, Karen L., Vollmer, Thomas R., Ward, Keith W., Zhang, Jin-Zhong
Publicado 2011

A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex

por VanDerMeid, Karl R., Su, Stephanie P., Krenzer, Kathleen L., Ward, Keith W., Zhang, Jin-Zhong
Publicado 2011

Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates

por Reisman, Scott A, Gahir, Sarabjit S, Lee, Chun-Yue I, Proksch, Joel W, Sakamoto, Mitsumasa, Ward, Keith W
Publicado 2019

The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction

por Sharma, Arpeeta, Rizky, Luddwi, Stefanovic, Nada, Tate, Mitchel, Ritchie, Rebecca H., Ward, Keith W., de Haan, Judy B.
Publicado 2017

BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells

por Zhang, Jin-Zhong, Cavet, Megan E., VanDerMeid, Karl R., Salvador-Silva, Mercedes, López, Francisco J., Ward, Keith W.
Publicado 2009

Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist

por Baiula, Monica, Spartà, Antonino, Bedini, Andrea, Carbonari, Gioia, Bucolo, Claudio, Ward, Keith W., Zhang, Jin-Zhong, Govoni, Paolo, Spampinato, Santi
Publicado 2011

Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers

por Reisman, Scott A., Goldsberry, Angela R., Lee, Chun-Yue I., O’Grady, Megan L., Proksch, Joel W., Ward, Keith W., Meyer, Colin J.
Publicado 2015